Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2018 Sep 26;9:2294. doi: 10.3389/fmicb.2018.02294

Deciphering the Interactome of Neisseria meningitidis With Human Brain Microvascular Endothelial Cells

Evelína Kánová 1, Irene Jiménez-Munguía 1, Petra Majerová 2, Zuzana Tkáčová 1, Katarína Bhide 1, Patrícia Mertinková 1, Lucia Pulzová 1, Andrej Kováč 2, Mangesh Bhide 1,2,*
PMCID: PMC6168680  PMID: 30319591

Abstract

Neisseria meningitidis is able to translocate the blood-brain barrier and cause meningitis. Bacterial translocation is a crucial step in the onset of neuroinvasion that involves interactions between pathogen surface proteins and host cells receptors. In this study, we applied a systematic workflow to recover and identify proteins of N. meningitidis that may interact with human brain microvascular endothelial cells (hBMECs). Biotinylated proteome of N. meningitidis was incubated with hBMECs, interacting proteins were recovered by affinity purification and identified by SWATH-MS. Interactome of N. meningitidis comprised of 41 potentially surface exposed proteins. These were assigned into groups based on their probability to interact with hBMECs: high priority candidates (21 outer membrane proteins), medium priority candidates (14 inner membrane proteins) and low priority candidates (six secretory proteins). Ontology analysis provided information for 17 out of 41 surface proteins. Based on the series of bioinformatic analyses and literature review, five surface proteins (adhesin MafA1, major outer membrane protein P.IB, putative adhesin/invasion, putative lipoprotein and membrane lipoprotein) were selected and their recombinant forms were produced for experimental validation of interaction with hBMECs by ELISA and immunocytochemistry. All candidates showed interaction with hBMECs. In this study, we present a high-throughput approach to generate a dataset of plausible meningococcal ligands followed by systematic bioinformatic pipeline to categorize the proteins for experimental validation.

Keywords: Neisseria meningitidis, hBMECs, bioinformatic pipeline, BBB, ligands, interactome, outer membrane proteins

Introduction

Neisseria meningitidis (also known as meningococcus) is primarily a human pathogen, which causes meningitis and fatal sepsis. It is normally a commensal in ~10% of the population (Greenfield et al., 1971). N. meningitidis colonizes the nasopharynx and can subsequently disseminate into the bloodstream allowing contact with the cells of neurovascular unit, which in turn facilitates translocation of bacteria across the blood-brain barrier (BBB) (Lambotin et al., 2005).

Human BBB tissue is composed of microvascular endothelial cells (hBMECs), pericytes, astrocytes and the basal lamina (Banks, 2015). This structure not only provides protection of the central nervous system (CNS) from microorganisms and toxins but also maintains the brain homeostasis and permits communication between blood and CNS (Banks, 2015). Despite highly sophisticated structure of BBB, some pathogens cross the BBB and invade CNS tissue (Doran et al., 2016).

The interactions between pathogen ligands and receptors on the cells of neurovascular unit initiate various cell signaling events, which may help pathogen to cross BBB. It has been reported that the type IV pili of N. meningitidis activate a β2-adrenergic receptor, which leads to the formation of cortical plaques and provides multiple signaling functions that promote bacterial infection (Miller et al., 2013). Opa and Opc surface proteins, located under the polysaccharide capsule, also bind to the endothelial cell receptors (Hardy et al., 2000). However, detailed picture of the ligand-receptor interactors that may take part in the translocation of N. meningitidis is still incomplete, which indicates a need of a high-throughput approach to reveal plausible meningococcal interactome.

The study of surface proteins containing highly hydrophobic moieties (e.g., membrane proteins) had been hampered by lack of appropriate technology. Gel-based techniques have been applied for the identification of bacterial membrane proteins as well as their receptors (Pulzova et al., 2011; Bencurova et al., 2015; Mlynarcik et al., 2015), however, these techniques are time-consuming and low-throughput. Moreover, gel-based techniques require a higher amount of biological material, which is an inconvenience in studies where the biological material is scarce (e.g., primary cells of the neurovascular unit). So far, high-throughput genomic approaches have been used to identify genes encoding proteins involved in pathogenicity of N. meningitidis (Tettelin et al., 2000; Zhang et al., 2014). This is first study that uses high-throughput mass-spectrometry (MS) to reveal the interactome of N. meningitidis with hBMECs. To identify plausible meningococcal interactome, techniques like labeling of the meningococcal proteome, high-throughput SWATH-MS and bioinformatic pipeline were used here.

Data generated from high-throughput technology requires rigorous data analysis approach to expose relevant biological information and shortlist important gene or protein candidates from large data subset. Bioinformatic analysis applied to a large set of data can help to improve selection of target molecules that are most relevant to the study. We have recently applied a set of bioinformatic tools to select pneumococcal surface proteins that may interact with hBMECs (Jimenez-Munguia et al., 2018). Similar bioinformatic pipeline was set in this study using freely available bioinformatic tools (such as CELLO, Psortb, SignalP, LipoP, HMMtop and TMHMM) to identify bacterial proteins that have less chance to bind host cells (e.g., cytoplasmic proteins) and select interacting proteins (plausible interactome).

In this research, by combining proteome labeling (biotinylation), SWATH-MS and performing bioinformatic analysis we attempted to identify ligands of N. meningitidis that may have potential to interact with hBMECs. Bioinformatic analysis was used to select five proteins candidates, which were then expressed in E. coli and subsequently shown to interact with hBMECs. Using this approach 41 meningococcal proteins that may interact with hBMECs were detected. We were able to validate interactions of selected bacterial ligands with hBMECs, which may play an important role in adherence.

Results presented in this publication together with our recently published study (Jimenez-Munguia et al., 2018), validate the experimental and bioinformatic approach designed to uncover potential bacterial ligands interacting with the host cells.

Materials and methods

N. meningitidis culture

N. meningitidis (isolate M1/03) was grown on Thayer Martin agar and a single isolated colony was transferred into 50 mL of Brain Heart Infusion Broth (BHI) enriched with 10 mM MgCl2. Bacterial culture were grown at 37°C and 5% CO2 until OD600 = 0.6 (mid-exponential phase). The neuroinvasive N. meningitidis isolate used in this study was kindly provided by the University Hospital Olomouc, Czech Republic. Phenotypic characterization (biochemical tests) and genotyping (multilocus sequence typing) was performed in the hospital laboratory.

Isolation of proteins of meningococci and biotin labeling

Proteins of N. meningitidis were extracted exactly as described before (Jimenez-Munguia et al., 2018) in non-denaturating lysis buffer containing 20 mM CHAPS, 300 mM NaCl, 0.01% sodium azide and 1 × proteases inhibitors, and biotinylated with EZ-Link Sulfo-NHS-LC-Biotin (Thermo Fisher Scientific) as per manufacturer's instructions. Biotinylation was confirmed with NeutrAvidin (Thermo Fisher Scientific) capture followed by SDS-PAGE as per manufacturer's instructions. Protein samples were quantified with the Bradford method, aliquoted and stored at −80°C until incubation with hBMECs.

Human brain microvascular endothelial cell culture

Human BMECs (D3 cell line), were cultured as previously described (Jimenez-Munguia et al., 2018). Cells were either incubated with biotinylated proteins of N. meningitidis or scrapped for protein isolation.

Isolation of proteins from hBMECs

Human BMECs were washed twice with EBM-2 medium (without any supplement) and once with phosphate buffer saline (pH 7.2) to remove albumin. Cells were scraped and resuspended in 1 mL of lysis solution (20 mM CHAPS, 300 mM NaCl, 0.1% sodium azide and 1 × proteases inhibitors). Proteins were extracted as previously described (Jimenez-Munguia et al., 2018) and stored in aliquots at −80°C until use.

The interaction between biotinylated proteins of N. meningitidis and hBMECs

The interaction was performed by incubating 200 μg of biotinylated proteins with confluent hBMECs in 25-mL cell culture flask for 1 h at 37°C in 5% of CO2. Cells were washed four times with Dulbecco's-PBS (Sigma) to remove unbound biotinylated proteins. The cell monolayer was then scraped in 2 mL PBS. Cells were centrifuged (3,000 × g, 10 min) and supernatant (S1) was kept on ice until use (please note that S1 may contain biotinylated proteins). The cell pellet was resuspended in 200 μL of lysis solution (cell surface protein isolation kit, Thermo Fisher Scientific) followed by 30 min incubation on ice (every 5 min cells were mixed well by 5 s of vortexing). Supernatant S1 was added to the cells in the lysis solution and five cycles of sonication (100% amplitude, 30 s on ice) were carried out. Proteins-containing supernatant (S2) was collected by centrifugation (10,000 × g, 5 min, 4°C). S2 was kept on ice until the capture of biotinylated proteins.

Presence of the biotinylated proteins in S2 was confirmed by dot blot as described earlier (Jimenez-Munguia et al., 2018).

Capture of biotinylated proteins from the cell extract (S2) and protein identification

Biotinylated proteins were captured on NeutrAvidin agarose beads (Thermo Fisher Scientific) according to the manufacturer's instructions. In short, NeutrAvidin agarose beads were washed with PBS and incubated with 200 μL of S2 for 1 h. After five wash steps with PBS, biotinylated proteins were eluted in 400 μL of 50 mM dithiothreitol (DTT) in PBS (pH 7.2). Proteins in eluate were identified by mass spectrometry as described in our previous report (Jimenez-Munguia et al., 2018).

Bioinformatic pipeline: a systematic selection of potential candidates for validation of interaction with hBMECs

We focused mainly on the cell wall proteins. First, subcellular location was assigned to remove proteins with less probability of interaction (intracellular proteins) and shortlist the surface exposed proteins. Second, surface interactome was classified into three categories according to the probability of interaction with host cells based on subcellular location. Third, ontology annotations were retrieved for surface-exposed proteins (Figure 1).

Figure 1.

Figure 1

Schematic representation of experimental and bioinformatic workflow performed in this study. Proteins of N. meningitidis were isolated1 and biotinylated2. Biotinylated proteome was incubated with human brain microvascular endothelial cells (hBMECs)3A. Unbound proteins were washed off3Band3C and interacting proteins bound to hBMECs were recovered from cell lyste3D with NeutrAvidin capture beads4aand4b, eluted with 50 mM DTT4c and identified by SWATH-MS5. Combination of bioinformatic tools was used for analyzing the interactome of N. meningitidis6. Surface proteins were grouped for selection of potential ligands. First analysis6−I (Psortb and Cello) segregated proteins according to subcellular location and intracellular proteins were removed. With the second set of analytic tools6−II, interactome was classified into the outer (group 1), inner (group 2) and secretory (group 3) proteins by applying algorithms to predict transmembrane helices (TMHMM and HMMtop) and type I and II signal peptides (SignalP and LipoP). Gene ontology (Blast2GO), UniProt and literature review6−III were performed further on proteins grouped above in 6-II. Bioinformatic pipeline enabled us to select most probable protein candidates that may interact with hBMECs and contribute in pathogenesis7. Those protein candidates were overexpressed in E.coli8 and used for validation with ELISA and immunocytochemistry9.

Primary predictions of subcellular location were assigned with freely available algorithms Psortb (http://www.psort.org/psortb/; Yu et al., 2010), and Cello (http://cello.life.nctu.edu.tw/; Yu et al., 2004). Presence of transmembrane domains was evaluated by TMHMM 2.0 (http://www.cbs.dtu.dk/services/TMHMM-2.0; Krogh et al., 2001) and HMMTOP (http://www.enzim.hu/hmmtop/; Tusnady and Simon, 2001). Presence of type-I and type-II signal peptides were predicted with SignalP (http://www.cbs.dtu.dk/services/SignalP-4.0/; Petersen et al., 2011) and LipoP (http://www.cbs.dtu.dk/services/LipoP; Juncker et al., 2003), respectively. With these predictors, candidates were categorized into the cytoplasmic, membrane-associated (or surface exposed) and secreted proteins.

Gene ontology was then retrieved only for surface-exposed proteins using Blast2GO (https://www.blast2go.com), which provided annotations from characterized proteins, whereas for non-annotated proteins annotations were retrieved from their orthologs (>95% identity). For proteins lacking annotations from Blast2GO, a search was performed in UniProt (http://www.uniprot.org/).

Synthesis of recombinant forms of the shortlisted proteins

Shortlisted protein candidates were overexpressed in E. coli. In brief, gene fragments encoding surface exposed region of proteins were amplified by PCR from genomic DNA of N. meningitidis. Amino acid and nucleotide sequences of amplified regions are presented in Supplementary Data Sheet 1. Detailed information on primer design, amplicon lengths and restriction enzymes used are presented in Supplementary Data Sheet 2. Digestion of amplified PCR products, ligation into a pQE-30-mCherry-GFP plasmid (in-house modified vector pQE-30 UA, Qiagen Comor et al., 2017, transformation and selection of clones were performed as described earlier Jimenez-Munguia et al., 2018. Insertion of encoding genes was confirmed by sequencing with vector specific primers UA Insertom F and R (Supplementary Data Sheet 2). Protein expression and purification with metal affinity chromatography were also carried out as described previously (Jimenez-Munguia et al., 2018). The purity of recombinant proteins was assessed by SDS-PAGE, while molecular mass was measured by MALDI-TOF MS. Protein concentration was measured using Bradford assay and aliquots of purified proteins were stored at −20°C in 20% glycerol until use.

Confirmation of interaction between recombinant ligands of meningococci and proteins of hBMECs

To confirm the interactions between recombinant ligands of meningococci and proteins of hBMECs an ELISA was performed as described previously (Jimenez-Munguia et al., 2018) with minor modifications. Briefly, wells were coated with protein extract of hBMECs diluted in coating buffer (8 μg of protein in 10 mM Na2CO3, 40 mM NaHCO3, pH 7.2). hBMECs proteins were incubated with various concentrations of each recombinant ligand (10, 20, or 40 μg/mL) for 1 h at room temperature. Bound recombinant proteins were detected with HisProbe-HRP (1 μg/mL dissolved in PBS containing 0.05% Tween-20, 30 min incubation at room temperature, Thermo Fisher Scientific). The reaction was developed with HRP substrate (LI-COR, Biosciences) and measured at 700 nm (Odyssey CLx, LI-COR Bioscience).

For input controls, 2 μg of each recombinant ligand were coated in the wells and detected with HisProbe-HRP. As negative controls, 8 μg of the cell extract of hBMECs were coated in the wells and incubated with HisProbe-HRP. As a positive control, 8 μg of the cell extract of hBMECs were incubated with domain III of protein E of West Nile Virus (known protein that interacts with hBMECs). The assay was performed in triplicates.

Confirmation of binding of ligands to the cultured hBMECs

Immunocytochemistry was performed as described previously (Jimenez-Munguia et al., 2018) with minor modifications. In brief, hBMECs were cultured on the coverslips coated with collagen type I (Sigma, USA) until 70% confluency. Cells were incubated with purified recombinant ligands (25 μg resuspended in 2 mL EBM-2 medium) for 2 h at 37°C in 5% CO2. Cells were washed with PBS containing Tween 20 (0.05%, PBST), fixed with ethanol/acetone (2:8 v/v) for 10 min and washed again three times. Bound recombinant proteins were detected with anti-His antibody conjugated with FITC, whereas nuclei were stained with DAPI (Sigma).

As negative control assay was performed without recombinant ligands. Domain III of protein E of West Nile Virus was also included in the experiment as positive control. Imaging was performed using LSM-710 microscope (Zeiss, Germany). The assay was performed in biological triplicates.

Results

Identification of putative surface interactome of N. meningitidis

Biotinylation of N. meningitidis proteome was evaluated by capturing labeled proteins on NeutrAvidin beads. We observed that most of the protein species were recovered when compared with the whole cell extract of N. meningitidis (Figure 2A). Recovery of the interacting biotinylated proteins in S2 eluate was evaluated with dot blot (Figure 2B). Further, with the SWATH-MS we succeeded in the identification of 84 proteins, which may bind to the endothelial cells (Supplementary Data Sheet 3).

Figure 2.

Figure 2

Biotinylation of N. meningitidis proteome and confirmation of the presence of biotinylated proteins bound to hBMECs. (A) Lane 1–Protein extract of meningococci prior to biotinylation separated on SDS-PAGE. Lane 2–Biotinylated proteins were incubated with NeutrAvidin capture beads, eluted with 50 mM DTT and separated on SDS-PAGE. (B) Dot blot. S2–Protein extract of hBMECs obtained after incubation with biotinylated proteins of meningococci spotted on the membrane and detected with IRdye®;800 Streptavidin. Negative control–Total protein extract of hBMECs was spotted on the membrane and incubated with IRdye®;800 Streptavidin, Input control–Biotinylated proteins of meningococci were spotted on the membrane and detected with IRdye®;800 Streptavidin.

Considering the importance of surface proteins in the crosstalk of pathogen and host cells, we used a systematic pipeline that combines series of bioinformatic tools and literature review to identify surface interactome of N. meningitidis. This pipeline was established to shortlist potential ligands by eliminating proteins with less chance to bind hBMECs (e.g., intracellular proteins) and segregating the surface proteins according to their probability to interact with host cells (e.g., outer membrane, inner membrane and secretory proteins). Out of 84 candidates identified by SWATH-MS, 43 proteins were predicted (Cello and Psortb algorithms) as cytoplasmic and were excluded from further analysis due to the low probability of their interaction with the host cells. The remaining 41 proteins were predicted as surface-exposed proteins and were considered as probable surface interactome against hBMECs (Figure 3). For a better selection of ligand candidates, surface interactome was further categorized (SignalP, LipoP, TMHMM, and HMMtop) into three groups according to the type of surface exposure (e.g., outer membrane, inner membrane and secretion). Surface exposure of ligand influences the probability of its contact with the receptor. Group 1. high priority candidates–consisted of 21 outer membrane proteins (including six lipoproteins), group 2. medium priority candidates–contained 14 inner membrane proteins (including three lipoproteins), and group 3. low priority candidates–contained six secretory proteins (Table 1; Figure 3).

Figure 3.

Figure 3

Prediction of subcellular location of identified proteins of N. meningitidis. Proteins identified by SWATH-MS were subjected to in silico prediction of subcellular location. Psortb and CELLO segregated proteins into two categories (cytoplasmic and surface proteins). Surface proteins (interactome) were further classified into three categories based on their probability of interaction with the host cells: high (containing outer membrane), medium (inner membrane) and low priority candidates (secretory proteins), by applying bioinformatic tools to predict transmembrane domains (TMHMM and HMMtop) and type I and II signal peptides (SignalP and LipoP).

Table 1.

Surface interactome of N. meningitidis against hBMECs identified in our study by SWATH-MS.

No. Entry Protein name Locus Psortb Cello SignalP LipoP TMHMM HMMTOP Consensus
GROUP 1. HIGH PRIORITY CANDIDATES (OUTER MEMBRANE PROTEINS)
1 Q7DDI3 Class 5 outer membrane protein NMB1053 Inner membrane Outer membrane Yes SP1 Outside Outside Outer membrane
2 Q9K187 LPS-assembly protein LptD NMB0280 Outer membrane Outer membrane Yes SP1 Outside Outside Outer membrane
3 Q9JXN3 VacJ-related protein NMB1961 Outer membrane Outer membrane Yes SP1 Outside Outside Outer membrane
4 Q9JXK7 Putative adhesin/invasion NMB1994 Outer membrane Extracellular Yes SP1 Outside Outside Outer membrane
5 Q9JS44 Adhesin MafA1 NMB0375 Unknown Outer membrane No SP2 Outside Outside Outer membrane
6 Q7DDH4 Putative lipoprotein NMB1126 Unknown Extracellular Yes SP2 Outside Outside Outer membrane
7 Q06379 Lactoferrin-binding protein A (Iron-regulated outer membrane protein A) NMB1540 Outer membrane Outer membrane Yes SP1 Outside 1 TMD Outer membrane
8 P0DH58 Major outer membrane protein P.IA NMB1429 Outer membrane Outer membrane Yes SP1 Outside 1 TMD Outer membrane
9 Q9K1M2 Putative outer membrane protein NMB0088 Outer membrane Outer membrane/Extracellular Yes SP1 Outside 1 TMD Outer membrane
10 P30690 Major outer membrane protein P.IB NMB2039 Outer membrane Outer membrane Yes SP1 1 TMD 1 TMD Outer membrane
11 P57026 Outer membrane protein H.8 NMB1533 Outer membrane Periplasmic Yes SP2 Outside Inside Outer membrane
12 Q9K0A7 LPS-assembly lipoprotein LptE NMB0707 Unknown Cytoplasmic No SP2 Outside Outside Outer membrane
13 Q9K0K8 Putative adhesin NMB0586 Outer membrane Periplasmic Yes SP1 Outside 1 TMD Outer membrane
14 Q9JXB7 Uncharacterized protein NMB2134 Outer membrane Outer membrane No SP1 1 TMD 1 TMD Outer membrane
15 Q9K0U9 Transferrin-binding protein 1 NMB0461 Outer membrane Outer membrane Yes SP1 Outside Outside Outer membrane
16 Q9K0V0 Transferrin-binding protein 2 (TBP-2) NMB0460 Unknown Extracellular No SP2 Outside 1 TMD Outer membrane
17 Q7DDB6 Probable TonB-dependent receptor NMB1497 Outer membrane Outer membrane No SP1 Outside Outside Outer membrane
18 Q7DDJ2 Adhesin NMB0992 Unknown Extracellular Yes SP1 Outside Outside Outer membrane
19 Q9JYP9 Putative lipoprotein NlpD NMB1483 Unknown Periplasmic Yes SP2 Outside Outside Outer membrane
20 Q9JXL6 Adhesion and penetration protein NMB1985 Outer membrane Outer membrane No SP1 1 TMD 1 TMD Outer membrane
21 Q9K165 TPR repeat-containing protein NMB0313 Unknown Outer membrane Yes SP1 Outside 1 TMD Outer membrane
GROUP 2. MEDIUM PRIORITY CANDIDATES (INNER MEMBRANE PROTEINS)
22 Q9JXD8 Putative adhesin complex protein NMB2095 Unknown Periplasmic Yes SP1 Outside 1 TMD Inner membrane
23 Q9JXT1 Lipoprotein NMB1898 Unknown Periplasmic Yes SP2 Outside 1 TMD Inner membrane
24 Q9JYG9 Putative lipoprotein NMB1592 Unknown Periplasmic No SP2 Outside 1 TMD Inner membrane
25 Q9K0S2 Uncharacterized protein NMB0506 Unknown Outer membrane/Periplasmic Yes SP1 1 TMD 1 TMD Inner membrane
26 Q9JZN1 Uncharacterized protein NMB0979 Inner membrane Periplasmic/Inner membrane Yes SP1 1 TMD 1 TMD Inner membrane
27 Q9JZR5 Uncharacterized protein NMB0928 Inner membrane Periplasmic No Cytoplasmic Outside 1 TMD Inner membrane
28 Q9JS13 Uncharacterized protein NMB1147 Cytoplasmic Periplasmic/Cytoplasmic No Cytoplasmic 1 TMD 1 TMD Inner membrane
29 Q9JY47 Uncharacterized protein NMB1749 Unknown Periplasmic No Cytoplasmic 1 TMD 1 TMD Inner membrane
30 Q9K1L2 Uncharacterized protein NMB0102 Inner membrane Inner membrane No Cytoplasmic 1 TMD 1 TMD Inner membrane
31 Q9K173 ComEA-related protein NMB0299 Inner membrane Periplasmic No TMD 1 TMD 1 TMD Inner membrane
32 Q9JXG2 Uncharacterized protein NMB2064 Inner membrane Inner membrane No TMD 1 TMD 1 TMD Inner membrane
33 Q7DDI4 DedA protein NMB1052 Unknown Inner membrane No TMD >1 TMD >1 TMD Inner membrane
34 Q7DDC1 Uncharacterized protein NMB1397 Inner membrane Cytoplasmic No TMD 1 TMD 1 TMD Inner membrane
35 Q7DD63 Outer membrane lipoprotein NMB1946 Inner membrane Periplasmic Yes SP2 Outside Outside Inner membrane
GROUP 3. LOW PRIORITY CANDIDATES (SECRETORY PROTEINS)
36 Q9JYV5 Iron-regulated protein FrpC NMB1415 Extracellular Extracellular/ No Cytoplasmic Outside Outside Secretory protein
37 Q9K0T0 Hemagglutinin/hemolysin-related protein NMB0493 Outer membrane Extracellular No Cytoplasmic Outside Outside Secretory protein secretory
38 Q9JY23 Hemagglutinin/hemolysin-related protein NMB1779 Outer membrane Extracellular No SP1 Outside Outside Secretory protein
39 Q9JYW0 FrpA/C-related protein NMB1409 Unknown Outer membrane No Cytoplasmic Outside Outside Secretory protein
40 Q9K0K9 Iron-regulated protein FrpA NMB0585 Extracellular Extracellular No Cytoplasmic Outside Outside Secretory protein
41 Q9JZ25 Uncharacterized protein NMB1327 Extracellular Periplasmic No Cytoplasmic Outside Outside Secretory protein

Categories for the subcellular location were established according to Psortb and Cello. SignalP and LipoP discriminate proteins containing a SP-I type and SP-II type signal peptides, respectively; and proteins containing transmembrane domains (TMD) were predicted by TMHMM and HMMTOP.

In silico analysis of the N. meningitidis surface interactome

The Blast2GO analysis applied to obtain gene ontology annotations showed that 58.6% of proteins (24 out of 41 candidates) or their orthologs are not annotated (neither in UniProt). Among annotated candidates, majority were related to transport (7 out of 41 proteins, included in group 1; Supplementary Data Sheet 2). Five proteins (NMB0280, NMB1497, NMB0461, NMB1126, and NMB1429) out of those seven were annotated as transport proteins, while two proteins are also involved in other functions, such as signal transduction and response to the stress (NMB2039) or cell adhesion and ion binding (NMB0586). A role in cell adhesion was also annotated to adhesin MafA1 protein (NMB0375). Four proteins from group 1 participate in ion binding, namely NMB0586, NMB0585, NMB1533 and the class 5 outer membrane protein NMB1053. The class 5 outer membrane protein and NMB1985 also possesses peptidase activity. Gene ontology terms related to the membrane organization, cellular component assembly, DNA binding, etc. were grouped into the category “miscellaneous” (Supplementary Data Sheet 2). Two proteins (NMB0707 and NMB1483) from group 1 and three proteins (NMB0299, NMB2095, and NMB1946) from group 2 belonged to this category.

As the Blast2GO failed to provide any relevant information for 24 non-annotated proteins, the literature review was performed. Information for four candidates was retrieved. Transferrin-binding protein 2 (NMB0460) and lactoferrin binding protein A (NMB1540) are associated with transport and ion binding, whereas Iron–regulated protein FrpC (NMB1415) and FrpA/C related protein (NMB1409) are reported as ion binding proteins (Supplementary Data Sheet 2).

Selection of protein candidates for validation of interaction with hBMECs

Following the bioinformatic pipeline, we selected five proteins for the production of their recombinant forms and subsequent validation of interaction with hBMECs. Four proteins were chosen from group 1 (outer membrane proteins) as follows: MafA1 (NMB0375) was selected as its role in adhesion of N. gonorrhoeae to the epithelial cells was described in the literature, however, its function in N. meningitidis is not studied yet. Similarly, a major outer membrane protein P.IB (NMB2039) is functionally characterized only in N. gonorrhoeae. The third candidate, putative adhesin/invasion (neisserial adhesin A-NadA, NMB1994) also possesses affinity to epithelial cells, while the fourth selected candidate (putative lipoprotein-NMB1126) is from lipoprotein family. The fifth protein (membrane lipoprotein, NMB1946) was predicted as an inner membrane protein (group 2) with bioinformatic tools used in this study, however, in the UniProt database it is annotated as an outer membrane protein and is one of possible vaccine candidate (Table 3 in Supplementary Data Sheet 2).

Validation of protein-protein interactions and ligand-hBMECs interaction

To confirm the interaction between shortlisted ligands and proteins of hBMECs, we produced recombinant forms of ligands (Table 2). Correct insertion of the gene of interest in the transformants, the purity of the recombinant proteins evaluated by SDS-PAGE and molecular masses assessed by MALDI-TOF are shown in Figure 4. The interaction between recombinant ligands and proteins of hBMECs was evaluated by ELISA (Figure 5A). Of note, control experiment without recombinant proteins (negative control, also used for background subtraction, Relative Fluorescence Unit RFU-0.073) confirmed the specificity of the assay. When recombinant ligands were used at 20 μg/mL, binding of putative lipoprotein NMB1126 was the strongest (RFU-2213.3, SD-331.3) followed by putative adhesin/invasion protein NMB1994 (RFU-1776.7, SD-275.4) and NMB2039 major outer membrane protein P.IB (RFU-1175, SD-190.9; Figure 5A). Dose-dependent interaction between hBMECs and recombinant ligands was also assessed, wherein we found that recombinant NMB2039, NMB1994, and NMB1126 were also able to interact with hBMECs at lower concentration (10 μg/mL; Figure 5A). The binding of NMB1946 to hBMECs at 20 μg/mL was the lowest (RFU-235 SD-11.1), however, at 40 μg/mL it appears to bind hBMECs on the same level as other proteins (Figure 5A). RFU for control experiment with domain III of protein E of West Nile virus (positive control) was 1,673.5 with standard deviation 798.8.

Table 2.

Potential ligands of N. meningitidis selected to produce their recombinant form.

No. Entry UniProt Protein name Locus Amino acids position in recombinant form Mr (kDa)
Theoretical Observed on SDS-PAGE
1 Q9JS44 Adhesin MafA1 NMB0375 G30–I307 59.3 ≈59
2 P30690 Major outer membrane protein P.IB NMB2039 A19–F331 62.3 ≈60
3 Q9JXK7 Putative adhesin/invasion (NadA) NMB1994 A135–I328 57.9 ≈60
4 Q7DDH4 Putative lipoprotein NMB1126 E23–G217 48.0 ≈49
5 Q7DD63 Outer membrane lipoprotein NMB1946 Q23–K287 56.0 ≈57

Figure 4.

Figure 4

Production of recombinant forms of the selected protein candidates. (A) Amplicons of the five gene coding fragments of potential ligands of meningococci resolved on the agarose gel; (B) purified recombinant proteins separated with SDS-PAGE; (C) molecular mass of recombinant proteins confirmed with MALDI-TOF/MS. Lane 1, adhesin MafA1 (NMB0375); Lane 2, major outer membrane protein P.IB (NMB2039); Lane 3, putative adhesin/invasion (NMB1994); Lane 4, putative lipoprotein (NMB1126); and Lane 5, outer membrane lipoprotein (NMB1946).

Figure 5.

Figure 5

Validation of interaction between selected protein candidates of N. meningitidis and cell lysate of hBMECs by semi-quantitative ELISA and immunocytochemistry. (A) Semi-quantitative ELISA performed to confirm the interaction between proteins of hBMECs and bacterial ligands (different concentrations). The interaction was detected with HisProbe conjugated with HRP and is shown in Relative Fluorescence Units (RFU). As positive control (+ control)–domain III protein E of West Nile virus was used. Negative control: (– control)–no ligand was added. Input control: recombinant ligand NMB0375 was coated and incubated with HisProbe-HRP and substrate. (B) Interaction of selected proteins of N. meningitidis with cultured hBMECs. Nuclei are stained with DAPI. Negative control–no recombinant ligand was included in the assay. Scale bars−10 μm. In both panels: NMB0375-adhesin MafA1; NMB2039-major outer membrane protein P.IB; NMB1994-putative adhesin/invasion; NMB1126-putative lipoprotein; NMB1946-outer membrane lipoprotein. Assays were performed in triplicate.

We also performed immunocytochemistry to corroborate the interaction between meningococcal ligands and hBMECs. The binding of NMB0375 adhesin MafA and NMB1994 putative adhesin/invasion on endothelial cells was evidently stronger than other three meningococcal ligands (Figure 5B). The binding of domain III of protein E of West Nile virus on endothelial cells was in correlation with its affinity observed in ELISA (Figures 5A,B).

Discussion

Microbial traversal of the BBB is a prerequisite for CNS infections. Pathogen invading CNS can traverse through the BBB using paracellular or transcellular routes. Initiation of bacterial translocation, via paracellular and transcellular pathways, occurs through the interactions of surface proteins of pathogen and the BBB (Pulzova et al., 2011). These protein-protein interactions (PPIs) provide valuable insight into the molecular networks that unfolds basic principles of pathogen invasion (Nicod et al., 2017). In this study, we attempted to identify the surface interactome of N. meningitidis plausibly interacting with hBMECs using high-throughput proteomic methods followed by an integrative bioinformatic analysis. Data from the available scientific publications were brought to draw appropriate interpretations.

Initially, we attempted to label surface proteome of the intact bacterial cells and extract biotin-labeled proteome. However, the labeling efficiency was low and few protein species were recovered (data are not shown). We speculate that capsule present on N. meningitidis, hinders labeling of the surface proteins with biotin. Thus, the whole proteome of meningococcus was biotinylated. As a result, it was possible to recover majority of meningococcal proteins that were used to identify interacting candidates with hBMECs (Figure 2A). Biotinylation of the whole cell proteomes or cell surface proteins has been performed in recent proteomic studies (Kay et al., 2009; Hormann et al., 2016; Jimenez-Munguia et al., 2018).

High-throughput approach to identify surface proteins of bacterial pathogens has been well-documented (Vytvytska et al., 2002; Jimenez-Munguia et al., 2018). Among the various mass spectrometry based methods, data-independent acquisition (SWATH-MS) technique is highly sensitive and robust method to accurately identify peptides (Ortea et al., 2016). Due to the high sensitivity of SWATH-MS even the minor interactors (or low abundant proteins) were possible to detect.

In many cases, high-throughput approaches generate a number of probable interactors, from which it is necessary to filter false positive hits. Thus, we have proposed a bioinformatic pipeline to specifically select proteins based on their highest probability of interaction with hBMECs. The implied method of exploiting multiple combinations of freely available bioinformatic tools is noteworthy.

Membrane proteins of Gram-negative bacteria predominantly consist of large, hydrophobic, antiparallel β-barrels that are localized into the membrane with the polar segments protruding at the extracellular region (Jeanteur et al., 1991; von Heijne, 1992). Therefore, it is difficult to resolve these proteins on 2D-PAGE. Applying SWATH-MS we were able to identify 84 proteins. Protein candidates were selected based on their subcellular location through the bioinformatic pipeline described in this work. As the surface exposed proteins are important in the initial stages of paracellular or transcellular pathways, cytoplasmic proteins were excluded from further analysis. The exclusion is also supported in other studies (Krumins and Stotzky, 1983; Maurel et al., 2004; Jimenez-Munguia et al., 2018). Apart from the surface proteins, 43 cytoplasmic proteins were identified that may bind with hBMECs directly or through other surface proteins (Rankl et al., 2006; Jeyachandran et al., 2010).

Thirty-five proteins were predicted as surface-associated in this study (plausible surface interactome). As far as the probability of interaction to the hBMECs is concerned, class 5 outer membrane proteins, ion binding proteins, adhesins and proteins from lipoprotein family are promising candidates in the surface interactome obtained in this study. Opc (NMB1053), a class 5 outer membrane protein was observed in the interactome. Class 5 proteins (e.g., Opc and Opa) and type IV pili (Tfp) enables adhesion of meningococci to the human cells (Virji et al., 1993; Virji, 2009). Earlier it was though that Opc and Opa are hidden under the polysaccharide capsule and are thus inaccessible to their receptors. However, it was later shown that expression of the capsule is diminished during meningococcal infection to allow interaction of surface ligands including Opa and Opc proteins with human cells (Virji et al., 1992, 1993; Dehio et al., 1998). Opa recognizes the members of CEACAM (carcinoembryonic antigen-related cell adhesion molecule) proteins on host cells (Virji et al., 1996), whereas Opc was shown to bind to HSPGs (heparan sulfate proteoglycans), and thus both proteins mediate adhesion and invasion of epithelial cells (de Vries et al., 1998). Although, Pili, Opc and Opa are abundant proteins on the neisserial surface (also referred as major adhesins), other surface proteins expressed in low amount (minor adhesins) might also play a crucial role in the bacterial adhesion and cell invasion. Role of minor adhesins in pathogenesis is predicted earlier (Hill et al., 2010). In this study, we have identified NMB1994-putative adhesin/invasion protein, NMB0586-putative adhesin, NMB2095-putative adhesin complex protein, NMB1985-adhesion/penetration protein and NMB0992-adhesin that may be designated as minor adhesins.

Proteins belonging to the lipoprotein family (e.g., components of the type IV pili) are important virulence factors of N. meningitidis as described in Kovacs-Simon et al (Kovacs-Simon et al., 2011). Lipoproteins are also attractive vaccine candidates, either in recombinant forms or in novel outer membrane vesicles (OMV) based vaccines. Putative lipoprotein (NMB1126), adhesin MafA1 (NMB0375), LPS-assembly lipoprotein LptE (NMB0707), outer membrane protein H.8 (NMB1533), putative lipoprotein NlpD (NMB1483) and lipoprotein (NMB1898) were among the identified candidates with lipid moiety in our study. Ion binding proteins are another group of proteins, considered as an important pathogenicity factor for meningococcal disease (Cornelissen and Sparling, 1994; Cornelissen, 2003). In the repertoire of surface interactome we found several ion binding candidates viz. transferrin-binding proteins Tbp1 NMB0461 and Tbp2 NMB0460 (mediating iron acquisition in the host), iron-regulated protein FrpA (NMB1409), iron-regulated protein FrpC (NMB1415), lactoferrin-binding protein A (NMB1540) and transferrin-binding protein 1 (NMB046; Table 1). Lactoferrin-binding protein A (LbpA) participates in recruitment of lactoferrin and is an important virulence factor of the meningococci (Pettersson et al., 1994). It is noteworthy that, lactoferrin is able to cross the BBB during an acute phase of inflammation and serves as a resource of iron during the invasion (Huettinger et al., 1998; Pettersson et al., 1998). This underlines the importance of LbpA in the process of neuroinvasion.

After segregation of protein candidates according to their subcellular location, bioinformatic pipeline described in this study was applied to collect relevant biological data for each shortlisted protein. Blast2GO provided gene ontology annotations for 17 protein interactors. The GO analysis has assigned cell adhesion, transport and ion binding functions for putative adhesin (NMB0586). Another putative adhesin/invasion protein (NMB1994), had 100% similarity with neisserial adhesin A (NadA), which has been reported to interact with epithelial cells (Capecchi et al., 2005). Interaction of NadA with hBMECs confirmed in this study (Figure 5) further adds to its significance in pathogenicity of N. meningitidis. Unfortunately, Blast2GO failed to retrieve annotations for 41.4% proteins, while literature review (Supplementary Data Sheet 2) provided information only on four non-annotated proteins [NMB0460, NMB1540, NMB1415 and NMB1409 that are associated with ion binding (Thompson and Sparling, 1993b; Thompson et al., 1993a)]. These non-annotated proteins needs further exploration to determine their biological function in pathogenesis.

Among five potential ligands selected for validation of interaction with hBMECs four proteins (NMB0375, NMB2039, NMB1994, and NMB1126) were selected from outer membrane proteins (group 1) because their surface exposure may facilitate contact and interaction with hBMECs. Relatively less is known about MafA1 (NMB0375) in N. meningitidis, however, it is reported that MafA1 of N. gonorrhoeae interacts with gangliotriosylceramide (GgO3) and gangliotetraosylceramide (GgO4) expressed on human endocervical cells (Paruchuri et al., 1990). Major outer membrane protein P.IB (NMB2039), another selected candidate belongs to the group of porins, abundantly localized on the outer membrane of pathogenic Neisseria (Wetzler, 2010). The interaction of P.IB protein with hBMECs and its subsequent effect on cell signaling has not yet been reviewed. However, it was found that P.IB of N. gonorrhoeae (PorBIA) binds to the scavenger receptor on endothelial cells (SREC-I), which leads to the bacterial uptake into endothelial or epithelial cells (Rechner et al., 2007). It is plausible that P.IB of N. meningitidis identified in the present study could bind to SREC-I of hBMECs. Third selected candidate, putative adhesin/invasion (neisserial adhesin A-NadA, NMB1994) is described to interact strongly with epithelial cells (Capecchi et al., 2005) but not with hBMECs. The fourth candidate selected for validation was the putative lipoprotein (NMB1126), a member of the lipoprotein family. NMB1946 (the fifth selected candidate) was reported to be a potential vaccine candidate against N. meningitidis (Pizza et al., 2000; Neumoin et al., 2011). NMB1946 and its homolog in N. gonorrhoeae were found upregulated in the presence of blood and a knockout mutant was found to be less competitive than the wild type strain (Echenique-Rivera et al., 2011). Interaction of above mentioned proteins with hBMECs was validated with both ELISA and immunocytochemistry (Figure 5).

To conclude, the proposed workflow is suitable for high-throughput screening of interacting proteins. This approach allowed us to identify interactome of the N. meningitidis against hBMECs for the selection of potential ligands. Furthermore, we have experimentally confirmed the interaction of five recombinant ligands with hBMECs. This systematic combination of proteomics and bioinformatic tools can potentially be applied to different microorganisms in deciphering their interactome at varying environmental conditions.

Author contributions

MB conceived the project. Experiments were designed by EK and MB. Biotinylation was performed by IJ-M and EK. Sequencing was carried out by KB and ZT. Human BMECs were grown by PeM, KB, and EK. LP, EK, and ZT produced recombinant proteins. AK performed MS analysis. PaM and PeM contributed in immunocytochemistry. The bioinformatic pipeline was proposed by EK and IJ-M. Data were analyzed by IJ-M and MB. EK, IJ-M, and MB wrote the manuscript. All authors read and approved the final manuscript.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank funding agencies APVV-14-0218 and VEGA 1/0258/15.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2018.02294/full#supplementary-material

References

  1. Banks W. A. (2015). The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun. 44, 1–8. 10.1016/j.bbi.2014.08.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bencurova E., Kovac A., Pulzova L., Gyuranecz M., Mlynarcik P., Mucha R., et al. (2015). Deciphering the protein interaction in adhesion of Francisella tularensis subsp. holarctica to the endothelial cells. Microb. Pathog. 81, 6–15. 10.1016/j.micpath.2015.03.007 [DOI] [PubMed] [Google Scholar]
  3. Capecchi B., Adu-Bobie J., Di Marcello F., Ciucchi L., Masignani V., Taddei A., et al. (2005). Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells. Mol. Microbiol. 55, 687–698. 10.1111/j.1365-2958.2004.04423.x [DOI] [PubMed] [Google Scholar]
  4. Comor L., Dolinska S., Bhide K., Pulzova L., Jimenez-Munguia I., Bencurova E., et al. (2017). Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis. Microb. Cell Fact. 16, 13. 10.1186/s12934-017-0630-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cornelissen C. N. (2003). Transferrin-iron uptake by Gram-negative bacteria. Front. Biosci. 8:d836-47. 10.2741/1076 [DOI] [PubMed] [Google Scholar]
  6. Cornelissen C. N., Sparling P. F. (1994). Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol. Microbiol. 14, 843–850. 10.1111/j.1365-2958.1994.tb01320.x [DOI] [PubMed] [Google Scholar]
  7. de Vries F. P., Cole R., Dankert J., Frosch M., van Putten J. P. (1998). Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol. Microbiol. 27, 1203–1212. 10.1046/j.1365-2958.1998.00763.x [DOI] [PubMed] [Google Scholar]
  8. Dehio C., Gray-Owen S. D., Meyer T. F. (1998). The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol. 6, 489–495. 10.1016/S0966-842X(98)01365-1 [DOI] [PubMed] [Google Scholar]
  9. Doran K. S., Fulde M., Gratz N., Kim B. J., Nau R., Prasadarao N., et al. (2016). Host-pathogen interactions in bacterial meningitis. Acta Neuropathol. 131, 185–209. 10.1007/s00401-015-1531-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Echenique-Rivera H., Muzzi A., Del Tordello E., Seib K. L., Francois P., Rappuoli R., et al. (2011). Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog. 7:e1002027. 10.1371/journal.ppat.1002027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Greenfield S., Sheehe P. R., Feldman H. A. (1971). Meningococcal carriage in a population of “normal” families. J. Infect. Dis. 123, 67–73. 10.1093/infdis/123.1.67 [DOI] [PubMed] [Google Scholar]
  12. Hardy S. J., Christodoulides M., Weller R. O., Heckels J. E. (2000). Interactions of Neisseria meningitidis with cells of the human meninges. Mol. Microbiol. 36, 817–829. 10.1046/j.1365-2958.2000.01923.x [DOI] [PubMed] [Google Scholar]
  13. Hill D. J., Griffiths N. J., Borodina E., Virji M. (2010). Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin. Sci. 118, 547–564. 10.1042/CS20090513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hormann K., Stukalov A., Muller A. C., Heinz L. X., Superti-Furga G., Colinge J., et al. (2016). A surface biotinylation strategy for reproducible plasma membrane protein purification and tracking of genetic and drug-induced alterations. J. Proteome Res. 15, 647–658. 10.1021/acs.jproteome.5b01066 [DOI] [PubMed] [Google Scholar]
  15. Huettinger M., Meilinger M., Gschwentner C., Lassmann H. (1998). The LDL-receptor family. Lactoferrin and lipid metabolism. Adv. Exp. Med. Biol. 443, 107–111. [PubMed] [Google Scholar]
  16. Jeanteur D., Lakey J. H., Pattus F. (1991). The bacterial porin superfamily: sequence alignment and structure prediction. Mol. Microbiol. 5, 2153–2164. 10.1111/j.1365-2958.1991.tb02145.x [DOI] [PubMed] [Google Scholar]
  17. Jeyachandran Y. L., Mielczarski J. A., Mielczarski E., Rai B. (2010). Efficiency of blocking of non-specific interaction of different proteins by BSA adsorbed on hydrophobic and hydrophilic surfaces. J. Colloid Interface Sci. 341, 136–142. 10.1016/j.jcis.2009.09.007 [DOI] [PubMed] [Google Scholar]
  18. Jimenez-Munguia I., Pulzova L., Kanova E., Tomeckova Z., Majerova P., Bhide K., et al. (2018). Proteomic and bioinformatic pipeline to screen the ligands of S. pneumoniae interacting with human brain microvascular endothelial cells. Sci. Rep. 8, 5231 10.1038/s41598-018-23485-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Juncker A. S., Willenbrock H., Von Heijne G., Brunak S., Nielsen H., Krogh A. (2003). Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci. 12, 1652–1662. 10.1110/ps.0303703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kay B. K., Thai S., Volgina V. V. (2009). High-throughput biotinylation of proteins. Methods Mol. Biol. 498, 185–196. 10.1007/978-1-59745-196-3_13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kovacs-Simon A., Titball R. W., Michell S. L. (2011). Lipoproteins of bacterial pathogens. Infect. Immun. 79, 548–561. 10.1128/IAI.00682-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Krogh A., Larsson B., von Heijne G., Sonnhammer E. L. (2001). Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567–580. 10.1006/jmbi.2000.4315 [DOI] [PubMed] [Google Scholar]
  23. Krumins S. A., Stotzky G. (1983). Protein-membrane interactions: specific vs. non-specific adsorption and binding of proteins and polyamino acids on erythroblasts transformed by Friend virus. Cell Biol. Int. Rep. 7, 625–635. 10.1016/0309-1651(83)90117-0 [DOI] [PubMed] [Google Scholar]
  24. Lambotin M., Hoffmann I., Laran-Chich M. P., Nassif X., Couraud P. O., Bourdoulous S. (2005). Invasion of endothelial cells by Neisseria meningitidis requires cortactin recruitment by a phosphoinositide-3-kinase/Rac1 signalling pathway triggered by the lipo-oligosaccharide. J. Cell Sci. 118, 3805–3816. 10.1242/jcs.02514 [DOI] [PubMed] [Google Scholar]
  25. Maurel D., Kniazeff J., Mathis G., Trinquet E., Pin J. P., Ansanay H. (2004). Cell surface detection of membrane protein interaction with homogeneous time-resolved fluorescence resonance energy transfer technology. Anal. Biochem. 329, 253–262. 10.1016/j.ab.2004.02.013 [DOI] [PubMed] [Google Scholar]
  26. Miller F., Lecuyer H., Join-Lambert O., Bourdoulous S., Marullo S., Nassif X., et al. (2013). Neisseria meningitidis colonization of the brain endothelium and cerebrospinal fluid invasion. Cell. Microbiol. 15, 512–519. 10.1111/cmi.12082 [DOI] [PubMed] [Google Scholar]
  27. Mlynarcik P., Pulzova L., Bencurova E., Kovac A., Dominguez M. A., Hresko S., et al. (2015). Deciphering the interface between a CD40 receptor and borrelial ligand OspA. Microbiol. Res. 170, 51–60. 10.1016/j.micres.2014.09.003 [DOI] [PubMed] [Google Scholar]
  28. Neumoin A., Leonchiks A., Petit P., Vuillard L., Pizza M., Soriani M., et al. (2011). 1H, 13C and 15N assignment of the GNA1946 outer membrane lipoprotein from Neisseria meningitidis. Biomol. NMR Assign. 5, 135–138. 10.1007/s12104-010-9285-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nicod C., Banaei-Esfahani A., Collins B. C. (2017). Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring. Curr. Opin. Microbiol. 39, 7–15. 10.1016/j.mib.2017.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ortea I., Rodriguez-Ariza A., Chicano-Galvez E., Arenas Vacas M. S., Jurado Gamez B. (2016). Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction. J. Proteomics 138, 106–114. 10.1016/j.jprot.2016.02.010 [DOI] [PubMed] [Google Scholar]
  31. Paruchuri D. K., Seifert H. S., Ajioka R. S., Karlsson K. A., So M. (1990). Identification and characterization of a Neisseria gonorrhoeae gene encoding a glycolipid-binding adhesin. Proc. Natl. Acad. Sci. U.S.A. 87, 333–337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Petersen T. N., Brunak S., von Heijne G., Nielsen H. (2011). SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8, 785–786. 10.1038/nmeth.1701 [DOI] [PubMed] [Google Scholar]
  33. Pettersson A., Klarenbeek V., van Deurzen J., Poolman J. T., Tommassen J. (1994). Molecular characterization of the structural gene for the lactoferrin receptor of the meningococcal strain H44/76. Microb. Pathog. 17, 395–408. [DOI] [PubMed] [Google Scholar]
  34. Pettersson A., Prinz T., Umar A., van der Biezen J., Tommassen J. (1998). Molecular characterization of LbpB, the second lactoferrin-binding protein of Neisseria meningitidis. Mol. Microbiol. 27, 599–610. [DOI] [PubMed] [Google Scholar]
  35. Pizza M., Scarlato V., Masignani V., Giuliani M. M., Arico B., Comanducci M., et al. (2000). Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816–1820. 10.1126/science.287.5459.1816 [DOI] [PubMed] [Google Scholar]
  36. Pulzova L., Kovac A., Mucha R., Mlynarcik P., Bencurova E., Madar M., et al. (2011). OspA-CD40 dyad: ligand-receptor interaction in the translocation of neuroinvasive Borrelia across the blood-brain barrier. Sci. Rep. 1, 86. 10.1038/srep00086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rankl M., Ruckstuhl T., Rabe M., Artus G. R., Walser A., Seeger S. (2006). Conformational reorientation of immunoglobulin G during nonspecific interaction with surfaces. ChemPhysChem 7, 837–846. 10.1002/cphc.200500448 [DOI] [PubMed] [Google Scholar]
  38. Rechner C., Kuhlewein C., Muller A., Schild H., Rudel T. (2007). Host glycoprotein Gp96 and scavenger receptor SREC interact with PorB of disseminating Neisseria gonorrhoeae in an epithelial invasion pathway. Cell Host Microbe 2, 393–403. 10.1016/j.chom.2007.11.002 [DOI] [PubMed] [Google Scholar]
  39. Tettelin H., Saunders N. J., Heidelberg J., Jeffries A. C., Nelson K. E., Eisen J. A., et al. (2000). Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287, 1809–1815. 10.1126/science.287.5459.1809 [DOI] [PubMed] [Google Scholar]
  40. Thompson S. A., Sparling P. F. (1993b). The RTX cytotoxin-related FrpA protein of Neisseria meningitidis is secreted extracellularly by meningococci and by HlyBD+ Escherichia coli. Infect. Immun. 61, 2906–2911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Thompson S. A., Wang L. L., Sparling P. F. (1993a). Cloning and nucleotide sequence of frpC, a second gene from Neisseria meningitidis encoding a protein similar to RTX cytotoxins. Mol. Microbiol. 9, 85–96. [DOI] [PubMed] [Google Scholar]
  42. Tusnady G. E., Simon I. (2001). The HMMTOP transmembrane topology prediction server. Bioinformatics 17, 849–850. 10.1093/bioinformatics/17.9.849 [DOI] [PubMed] [Google Scholar]
  43. Virji M. (2009). Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat. Rev. Microbiol. 7, 274–286. 10.1038/nrmicro2097 [DOI] [PubMed] [Google Scholar]
  44. Virji M., Makepeace K., Ferguson D. J., Achtman M., Moxon E. R. (1993). Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol. Microbiol. 10, 499–510. 10.1111/j.1365-2958.1993.tb00922.x [DOI] [PubMed] [Google Scholar]
  45. Virji M., Makepeace K., Ferguson D. J., Achtman M., Sarkari J., Moxon E. R. (1992). Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol. Microbiol. 6, 2785–2795. 10.1111/j.1365-2958.1992.tb01458.x [DOI] [PubMed] [Google Scholar]
  46. Virji M., Makepeace K., Ferguson D. J., Watt S. M. (1996). Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol. Microbiol. 22, 941–950. 10.1046/j.1365-2958.1996.01551.x [DOI] [PubMed] [Google Scholar]
  47. von Heijne G. (1992). Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J. Mol. Biol. 225, 487–494. 10.1016/0022-2836(92)90934-C [DOI] [PubMed] [Google Scholar]
  48. Vytvytska O., Nagy E., Bluggel M., Meyer H. E., Kurzbauer R., Huber L. A., et al. (2002). Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2, 580–590. [DOI] [PubMed] [Google Scholar]
  49. Wetzler L. M. (2010). Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity. Fut. Microbiol. 5, 749–758. 10.2217/fmb.10.41 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yu C. S., Lin C. J., Hwang J. K. (2004). Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci. 13, 1402–1406. 10.1110/ps.03479604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yu N. Y., Wagner J. R., Laird M. R., Melli G., Rey S., Lo R., et al. (2010). PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26, 1608–1615. 10.1093/bioinformatics/btq249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zhang Y., Yang J., Xu L., Zhu Y., Liu B., Shao Z., et al. (2014). Complete genome sequence of Neisseria meningitidis serogroup A strain NMA510612, isolated from a patient with bacterial meningitis in China. Genome Announc. 2:e00360-14. 10.1128/genomeA.00360-14 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES